Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Polyrhamnose polysaccharide refers to a rhamnose-rich linear polymer (often called rhamnan) that forms a conserved backbone in the cell wall glycopolymers of many Gram-positive bacteria, notably streptococci and lactococci.[2] The backbone commonly consists of repeating →3)α-L-Rha(1→2)α-L-Rha(1→ units, which are variably substituted with species- and serotype-specific side chains such as glucose or N-acetylglucosamine and can be further modified with moieties like glycerol phosphate.[3] This rhamnan core and its decorations (collectively termed Rha-CWPS, SCC in S. mutans, or GAC in S. pyogenes) contribute to cell wall architecture, serotype specificity, and interactions with peptidoglycan via LCP-family enzymes.[2][3] While not a receptor, enzyme, or classical human therapeutic target, the polyrhamnose structure serves as an antigenic scaffold that can be exploited in vaccine design; engineered forms of the Group A carbohydrate lacking GlcNAc side chains have been conjugated to proteins to generate candidate conjugate vaccine antigens.[4]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polyrhamnose polysaccharide.